Merck says to seek 3 drug approvals in 2007
601819
Merck & Co. on Tuesday said it aims to  seek U.S. approvals next year for drugs to treat HIV,  cholesterol and insomnia and aims to have another four products  in late-stage trials by mid-2007.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
16298
The drug company presents 2007's numbers and gives 2008 guidance.
171506
Merck &amp; Co. is helping bankroll efforts to pass state laws requiring girls as young as 11 or 12 to receive the drugmaker's new vaccine against the sexually transmitted cervical-cancer virus.
280845
Merck &amp; Co.&#39;s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday.
458999
Merck & Co.  said on Friday it  would delay seeking approval for a combination pill designed to  lower "bad" cholesterol, increase "good" cholesterol and avoid  a common side effect of one of the ingredients.
195535
Merck & Co. MRK.N and two other U.S.  drugmakers posted weak third-quarter results on Thursday, hurt  by intensifying competition and the loss of sales from drugs  found to be potentially dangerous.
682721
Biotech companies, medical device  makers and food manufacturers joined patient groups and three  former U.S. health secretaries on Monday in calling for  increased funding for the Food and Drug Administration.
620499
Sales of its lead drug should expand in 2008.
223061
Drug companies could soon make more experimental drugs available for a fee to more patients with serious or life-threatening diseases that have no approved treatments, under revised rules the U.S. Food and Drug Administration proposed on Monday.
465386
An experimental HIV drug from Merck &amp; Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
643175
Now that Merck has removed Vioxx from the market, drugs in the same class - both available and awaiting approval - are undergoing renewed scrutiny.
496748
The Food and Drug Administration told Merck &amp; Co. that the company needs to supply more data for its Arcoxia pain treatment to gain approval, the pharmaceutical company said Friday.
514713
BETHESDA, Md.  - U.S. advisers are set to decide  on Friday whether they will recommend approval for Merck & Co.  Inc.'s plan to sell a cholesterol-lowering medicine on  drugstore shelves without a prescription.
179055
Drugmaker Merck has set up an independent committee to review the firm&#39;s actions prior to the withdrawal of its painkiller Vioxx from the market in September.
200022
NEW YORK, Nov. 29 -- Drugmaker Merck & Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that would guarantee large severance packages to 230 top executives if the company merges or is taken over.